RSV Unveiled: Breaking Down the New Vaccines on the Block

QPD Podcast by Cambiar Investors

Episode notes

In this episode of the QPD Podcast, Dr. Raymond Blum, a board-certified expert in internal medicine and infectious diseases, discusses the impact of respiratory syncytial virus (RSV).

We explore the revolutionary new vaccines, their development, effectiveness, and impact on public health.

Keywords
RSVhealthcarevaccinesGSKArexvyinternational stocks